Sunesis Pharmaceuticals to Report Fourth Quarter and Full-Year 2007 Financial Results on March 11, 2008
March 05 2008 - 7:00AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., March 5 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), a clinical-stage
biopharmaceutical company developing novel anticancer therapeutics,
today announced that management will hold an investor conference
call on Tuesday, March 11, 2008 at 10:30 a.m. ET/7:30 a.m. PT to
discuss financial results for the fourth quarter and fiscal year
ended December 31, 2007. Individual and institutional investors can
access the call via (877) 604- 9668 (U.S. and Canada) or (719)
325-4904 (international). To access the live audio webcast or the
subsequent archived recording, visit the "Investors and Media -
Calendar of Events" section of the Sunesis website at
http://www.sunesis.com/. Please log on to Sunesis' website several
minutes prior to the start of the presentation to ensure adequate
time for any software download that may be necessary. About Sunesis
Pharmaceuticals Sunesis is a clinical-stage biopharmaceutical
company focused on the discovery, development and commercialization
of novel small molecule therapeutics for oncology and other serious
diseases. Sunesis has built a broad product candidate portfolio
through internal discovery and in-licensing of novel cancer
therapeutics. Sunesis is advancing its product candidates through
in-house research and development efforts and strategic
collaborations with leading pharmaceutical and biopharmaceutical
companies. For additional information on Sunesis Pharmaceuticals,
please visit http://www.sunesis.com/. DATASOURCE: Sunesis
Pharmaceuticals, Inc. CONTACT: Investors, Eric Bjerkholt, SVP,
Corp. Development & Finance of Sunesis Pharmaceuticals, Inc.,
+1-650-266-3717; or Media, Karen L. Bergman or Michelle Corral of
BCC Partners, +1-650-575-1509 or +1-415-794-8662 Web site:
http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals (MM) News Articles